| Serial Number | 79287897 |
| Word Mark | SAGASEQ |
| Filing Date | Thursday, March 5, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 2, 2021 |
| Registration Number | 6279624 |
| Registration Date | Tuesday, March 2, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 15, 2020 |
| Goods and Services | Nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; diagnostic preparations and materials, namely, medical diagnostic reagents; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; clinical medical reagents; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic testing materials for medical use; genetic identity tests comprised of reagents for medical purposes; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for analysis of blood and other liquids; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; reactants for medical diagnosis being diagnostic reagents for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for blood grouping for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic pregnancy tests; veterinary diagnostic reagents |
| Goods and Services | Genetic counseling; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis being medical analysis for diagnostic and treatment of persons provided by medical laboratories; medical and healthcare services; medical monitoring of patients; stem cell therapy services; medical services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; medical consultancy and information services relating to medical products; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons relating to cancer and infectious diseases; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients relating to cancer and infectious diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons for cancer and infectious diseases provided by a medical laboratory; medical and health services relating to DNA, genetics and genetic testing; medical care and analysis of cancer diagnosis relating to patient treatment; medical consultations; medical diagnostic services; medical evaluation services; medical analysis services for diagnostic and treatment purposes of blood samples taken from patients provided by medical laboratories; medical screening; medical services for the treatment of skin cancer; medical services in the field of oncology; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; prostate cancer screening services; providing cancer screening services; providing news and information in the field of medicine; RNA or DNA analysis for cancer diagnosis and prognosis; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for the preparation of medical reports relating to health care; technical consultancy services relating to medical health; testicular cancer screening services |
| Goods and Services | Analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research in the field of cancer and infectious diseases and medical research; clinical research in the field of cancer and infectious diseases; clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to laboratory testing; consultancy relating to pharmaceutical research and development; medical laboratory services; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating to medical and veterinary pharmaceutical and diagnostic research and development; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 19, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 19, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 19, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Event Date | Event Description |
| Monday, July 24, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, December 15, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, December 15, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 15, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, December 15, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, December 15, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 15, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, January 21, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, June 28, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, June 3, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, June 3, 2021 | FINAL DISPOSITION PROCESSED |
| Wednesday, June 2, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, March 2, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 26, 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Thursday, January 14, 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, December 15, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 15, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 25, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, November 13, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, November 11, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 11, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 11, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 11, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 11, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 11, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, September 8, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Friday, August 21, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 20, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 19, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 19, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 14, 2020 | REFUSAL PROCESSED BY IB |
| Monday, July 27, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, July 27, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 23, 2020 | APPLICATION FILING RECEIPT MAILED |
| Sunday, June 21, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, June 20, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, June 19, 2020 | ASSIGNED TO EXAMINER |
| Friday, June 19, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 18, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |